Journal articles on the topic 'Papillomavirus humain (HPV)'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Papillomavirus humain (HPV).'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Ouedraogo, Rogomenoma Alice, Théodora Mahoukèdè Zohoncon, Abdoul Karim Ouattara, and Jacques Simpore. "Prédominance du papillomavirus humain 56 dans une sous-population de femmes sexuellement actives à Garango, Centre-Est, Burkina Faso." Journal of Applied Biosciences 150 (June 30, 2020): 15499–509. http://dx.doi.org/10.35759/jabs.150.10.
Gavillon, N., H. Vervaet, E. Derniaux, P. Terrosi, O. Graesslin, and C. Quereux. "Papillomavirus humain (HPV) : comment ai-je attrapé ça ?" Gynécologie Obstétrique & Fertilité 38, no. 3 (March 2010): 199–204. http://dx.doi.org/10.1016/j.gyobfe.2010.01.003.
Ezebialu, C. U., I. U. Ezebialu, and C. C. Ezenyeaku. "Persistence of cervical human papillomavirus infection among cohort of women in Awka, Nigeria." African Journal of Clinical and Experimental Microbiology 22, no. 3 (July 2, 2021): 344–51. http://dx.doi.org/10.4314/ajcem.v22i3.5.
Manus, Jean-Marie. "Brève : Vaccin à papillomavirus humain (HPV) pour filles et garçons." Revue Francophone des Laboratoires 2021, no. 529 (February 2021): 19. http://dx.doi.org/10.1016/s1773-035x(21)00026-5.
Macdonald, Liane, Shelley Deeks, and Carolyn Doyle. "A Public Health Perspective on HPV Vaccination: Response to The HPV Vaccination Campaign: A Project of Moral Regulation in an Era of Biopolitics." Canadian Journal of Sociology 35, no. 4 (September 28, 2010): 627–32. http://dx.doi.org/10.29173/cjs8977.
Oumara, M., S. Guede, Abdou A. Issa, Garba S. Oumarou, Diaouga H. Soumana, Lankoande Z. Salifou, Yacouba M. Chaibou, R. M. Garba, and M. Nayama. "Epidémiologie et génotypage du papillomavirus humain au Niger : A propos de 30 cas au Centre National Santé de la Reproduction de Niamey." Journal de la Recherche Scientifique de l’Université de Lomé 26, no. 1 (April 18, 2024): 177–86. http://dx.doi.org/10.4314/jrsul.v26i1.24.
Perrin, Andry. "Vaccination contre le papillomavirus humain (HPV) chez le sujet masculin : évidence et pratique." Revue Médicale Suisse 15, no. 673 (2019): 2202–4. http://dx.doi.org/10.53738/revmed.2019.15.673.2202.
Farge, G., E. Guyot, M. Belhassen, M. Bérard, F. Jacoud, L. Bensimon, G. De pouvourville, and J. Baldauf. "Couverture vaccinale contre le papillomavirus humain (HPV) chez les adolescents français: étude PAPILLON." Gynécologie Obstétrique Fertilité & Sénologie 52, no. 5 (May 2024): 349. http://dx.doi.org/10.1016/j.gofs.2024.03.016.
Guyot, E., G. Farge, M. Belhassen, M. Berard, F. Jacoud, L. Bensimon, G. de Pouvourville, and J.-J. Baldauf. "Couverture vaccinale contre le papillomavirus humain (HPV) chez les adolescents français - Étude PAPILLON." Journal of Epidemiology and Population Health 72 (March 2024): 202216. http://dx.doi.org/10.1016/j.jeph.2024.202216.
Dib, Fadia, Gwenn Menvielle, and Pierre Chauvin. "Tous égaux face aux papillomavirus ? L’infection et la vaccination HPV au prisme des inégalités sociales de santé." Questions de santé publique, no. 38 (November 2019): 1–8. http://dx.doi.org/10.1051/qsp/2019038.
Adejo, D. S., M. Aminu, E. E. Ella, O. A. Oguntayo, and O. F. Obishakin. "Prevalence of high-risk human papillomavirus genotypes among apparently healthy women with normal and abnormal cervical cytology in Kaduna State, Nigeria." African Journal of Clinical and Experimental Microbiology 25, no. 1 (January 16, 2024): 17–27. http://dx.doi.org/10.4314/ajcem.v25i1.3.
Pépin, Dominique, Johanne Le Bihan-Le Beyec, Danièle Hugol, Jacques Diebold, Anne Gompel, Jean Chambaz, and Jean-Marc Lacorte. "Stratégie de dépistage par PCR des infections a papillomavirus humain (HPV) sur les prélèvements cervico-vaginaux." Revue Française des Laboratoires 1999, no. 318 (December 1999): 23–28. http://dx.doi.org/10.1016/s0338-9898(99)80419-3.
Riethmuller, D., C. Gabelle, R. Ramanah, J. L. Sautière, J. L. Prétet, J. P. Schaal, B. Kantelip, C. Mougin, and R. Maillet. "Intérêt de la recherche du papillomavirus humain (HPV) dans le suivi post-conisation des CIN2–3." Journal de Gynécologie Obstétrique et Biologie de la Reproduction 37, no. 4 (June 2008): 329–37. http://dx.doi.org/10.1016/j.jgyn.2007.12.012.
Wafo, E., D. Ivorra-Deleuze, C. Thuillier, and R. Rouzier. "Estimation de l’évolution des connaissances sur les infections à Papillomavirus humain (HPV) : résultats d’une enquête téléphonique." Journal de Gynécologie Obstétrique et Biologie de la Reproduction 39, no. 4 (June 2010): 305–9. http://dx.doi.org/10.1016/j.jgyn.2010.03.007.
Baldauf, J., G. Farge, E. Guyot, M. Belhassen, M. Bérard, F. Jacoud, L. Bensimon, and G. De Pouvourville. "Couverture vaccinale contre le papillomavirus humain (HPV) chez les adolescents français et inégalités sociales : Étude PAPILLON." Médecine et Maladies Infectieuses Formation 3, no. 2 (June 2024): S130—S131. http://dx.doi.org/10.1016/j.mmifmc.2024.04.365.
Mezin, Laetitia, Anne Rousseau, Yann Sellier, Luis Teixeira, Clémence Schantz, and Vaxi-Pap. "« Un vaccin qui reste quand même à part » : Papillomavirus et vaccination en France." Santé Publique Vol. 35, no. 2 (August 2, 2023): 127–37. http://dx.doi.org/10.3917/spub.232.0127.
BOUSSAGEON, R., E. FERRAT, M. FLORI, S. ERPELDINGER, C. MAYNIE-FRANCOIS, I. SUPPER, and D. POUCHAIN. "Vaccin HPV et prévention du cancer du col de l’utérus." EXERCER 31, no. 165 (September 1, 2020): 310–15. http://dx.doi.org/10.56746/exercer.2020.165.310.
Ismail, S., and S. Deeks. "Résumé de la mise à jour du Comité consultatif national de l’immunisation visant le calendrier d’immunisation recommandé pour le vaccin contre le virus du papillome humain." Relevé des maladies transmissibles au Canada 41, S3 (April 20, 2015): 12–14. http://dx.doi.org/10.14745/ccdr.v41is3a03f.
Totten, S., A. Severini, GC Jayaraman, ST Faybush, G. Johnson, AA Demers, I. Sobol, Y. Mao, and Wong Wong. "Résultats des infections au virus du papillome humain (VPH) spécifiques au type et des tests Pap chez les femmes inuites et non inuites au Nunavut, Canada." Relevé des maladies transmissibles au Canada 41, no. 3 (March 5, 2015): 46–54. http://dx.doi.org/10.14745/ccdr.v41i03a01f.
Tunis, MC, and SL Deeks. "Résumé des recommandations mises à jour du Comité consultatif national de l’immunisation sur les vaccins contre le virus du papillome humain (VPH) : Intervalles minimaux entre les doses du vaccin nonavalent contre le VPH dans le calendrier d’immunisation contre le VPH." Relevé des maladies transmissibles au Canada 42, no. 7 (July 7, 2016): 166–69. http://dx.doi.org/10.14745/ccdr.v42i07a03f.
Deeks, SL, MC Tunis, and S. Ismail. "Résumé de la mise à jour du CCNI sur l'utilisation recommandée du vaccin contre le virus du papillome humain (VPH) : Calendrier de vaccination du vaccin nonavalent contre le VPH à deux doses et utilisation des vaccins anti-VPH chez les populations." Relevé des maladies transmissibles au Canada 43, no. 6 (June 1, 2017): 155–59. http://dx.doi.org/10.14745/ccdr.v43i06a04f.
Qədir qızı Əbilova, Rübayə, Gülnarə Alışa qızı Cəfərova, and Hafiz Maarif oğlu Osmanov. "The role of viruses and bacteria in the development of cancer." NATURE AND SCIENCE 11, no. 06 (August 23, 2021): 5–10. http://dx.doi.org/10.36719/2707-1146/11/5-10.
Wanja Karani, Lucy, Stanslaus Musyoki, Robert Orina, Christopher Khayeka-Wandabwa, and Benuel Nyagaka. "Cytological physiognomies and genotype distribution of human papillomaviruses among HPV/HIV co-infected and HPV mono-infected women." African Health Sciences 21, no. 1 (April 16, 2021): 254–62. http://dx.doi.org/10.4314/ahs.v21i1.33.
Francies, Flavia Zita, and Zodwa Dlamini. "Aberrant Splicing Events and Epigenetics in Viral Oncogenomics: Current Therapeutic Strategies." Cells 10, no. 2 (January 26, 2021): 239. http://dx.doi.org/10.3390/cells10020239.
Bigoni, Jérôme, Rosa Catarino, Caroline Benski, Manuela Viviano, Maria Munoz, Honoré Tilahizandry, Patrick Petignat, and Pierre Vassilakos. "High Burden of Human Papillomavirus Infection in Madagascar: Comparison With Other Sexually Transmitted Infections." Infectious Diseases: Research and Treatment 11 (January 1, 2018): 117863371775268. http://dx.doi.org/10.1177/1178633717752686.
Conway, M. J., and C. Meyers. "Replication and Assembly of Human Papillomaviruses." Journal of Dental Research 88, no. 4 (April 2009): 307–17. http://dx.doi.org/10.1177/0022034509333446.
Varsani, Arvind, Eric van der Walt, Livio Heath, Edward P. Rybicki, Anna Lise Williamson, and Darren P. Martin. "Evidence of ancient papillomavirus recombination." Journal of General Virology 87, no. 9 (September 1, 2006): 2527–31. http://dx.doi.org/10.1099/vir.0.81917-0.
Gudenkauf, Franciska J., and Aaron P. Thrift. "Racial/Ethnic Differences in Cancers Attributable to Preventable Infectious Agents in Texas, 2015." Public Health Reports 135, no. 6 (October 20, 2020): 805–12. http://dx.doi.org/10.1177/0033354920954497.
Alberts, Catharina J., Isabelle Heard, Ana Canestri, Lucie Marchand, Jean-François Fléjou, Lionel Piroth, Tristan Ferry, et al. "Incidence and Clearance of Anal Human Papillomavirus (HPV)-16 and HPV-18 Infection, and Their Determinants, Among Human Immunodeficiency Virus-Infected Men Who Have Sex With Men in France." Journal of Infectious Diseases 221, no. 9 (November 22, 2019): 1488–93. http://dx.doi.org/10.1093/infdis/jiz623.
Bieńkowski, Carlo, Zuzanna Żak, Filip Fijołek, Martyna Cholewik, Maciej Stępień, Agata Skrzat-Klapaczyńska, and Justyna D. Kowalska. "Immunological and Clinical Responses to Vaccinations among Adults Living with HIV." Life 14, no. 5 (April 24, 2024): 540. http://dx.doi.org/10.3390/life14050540.
Makhorina, T. V., K. E. Boeva, G. V. Malyshkina, and A. V. Semenov. "MECHANISMS OF EVACUATION OF THE HUMAN PAPILLOMA VIRUS FROM THE IMMUNE RESPONSE IN HIV-INFECTED PEOPLE." Laboratornaya i klinicheskaya meditsina. Farmatsiya, no. 8 (2023): 46–59. http://dx.doi.org/10.14489/lcmp.2023.02.pp.046-059.
Mbimenyuy, C. M., J. F. Cho, A. E. Mugyia, G. M. Ikomey, D. M. Tebit, and D. A. Nota. "Comparative HPV genotype distribution among women with normal and abnormal cervical cytology in Yaoundé, Cameroon." African Journal of Clinical and Experimental Microbiology 24, no. 2 (April 18, 2023): 158–67. http://dx.doi.org/10.4314/ajcem.v24i2.5.
Awua, Adolf K., Alberto Severini, Edwin K. Wiredu, Edwin A. Afari, Vanessa A. Zubach, and Richard M. K. Adanu. "Self-Collected Specimens Revealed a Higher Vaccine- and Non-Vaccine-Type Human Papillomavirus Prevalences in a Cross-Sectional Study in Akuse." Advances in Preventive Medicine 2020 (January 22, 2020): 1–13. http://dx.doi.org/10.1155/2020/8343169.
Sharipova, I. P., and E. I. Musabaev. "HUMAN PAPILLOMAVIRUS INFECTION AND CERVICAL CANCER (OWERWIEW)." UZBEK MEDICAL JOURNAL 2, no. 4 (April 30, 2021): 23–29. http://dx.doi.org/10.26739/2181-0664-2021-4-4.
Syrjänen, S. "Human Papillomavirus Infection and Its Association with HIV." Advances in Dental Research 23, no. 1 (March 25, 2011): 84–89. http://dx.doi.org/10.1177/0022034511399914.
Volgareva, G. M. "PAPILLOMAVIRAL CARCINOGENESIS. SIGNIFICANT ACHIEVEMENTS AND SPECIFIC CHALLENGES. PART 3. THREE LEVELS OF CERVICAL CANCER PREVENTION AND TREATMENT." Russian Journal of Biotherapy 19, no. 3 (October 13, 2020): 6–11. http://dx.doi.org/10.17650/1726-9784-2020-19-3-6-11.
Tong, Yan, Philip Tonui, Aaron Ermel, Omenge Orang’o, Nelson Wong, Maina Titus, Stephen Kiptoo, Kapten Muthoka, Patrick J. Loehrer, and Darron R. Brown. "Persistence of oncogenic and non-oncogenic human papillomavirus is associated with human immunodeficiency virus infection in Kenyan women." SAGE Open Medicine 8 (January 2020): 205031212094513. http://dx.doi.org/10.1177/2050312120945138.
Yao, Pang, Iona Millwood, Christiana Kartsonaki, Alexander J. Mentzer, Naomi Allen, Rima Jeske, Julia Butt, et al. "Sero-prevalence of 19 infectious pathogens and associated factors among middle-aged and elderly Chinese adults: a cross-sectional study." BMJ Open 12, no. 5 (May 2022): e058353. http://dx.doi.org/10.1136/bmjopen-2021-058353.
López-Martínez, Jael, María del Pilar Gabriel de la Torre, Cristian Cruz Ochoa, Lucía Martínez-Martínez, and Miguel Ángel Mayoral Chávez. "Los virus como detonante oncogénico." Tequio 1, no. 2 (January 27, 2018): 57–67. http://dx.doi.org/10.53331/teq.v1i2.5493.
KAWANA, Kei. "Human papillomavirus prophylactic vaccine." Uirusu 62, no. 1 (2012): 79–86. http://dx.doi.org/10.2222/jsv.62.79.
Zou, Nianxiang, Jen-Sing Liu, Shu-Ru Kuo, Thomas R. Broker, and Louise T. Chow. "The Carboxyl-Terminal Region of the Human Papillomavirus Type 16 E1 Protein Determines E2 Protein Specificity during DNA Replication." Journal of Virology 72, no. 4 (April 1, 1998): 3436–41. http://dx.doi.org/10.1128/jvi.72.4.3436-3441.1998.
Romero-Masters, James C., Paul F. Lambert, and Karl Munger. "Molecular Mechanisms of MmuPV1 E6 and E7 and Implications for Human Disease." Viruses 14, no. 10 (September 28, 2022): 2138. http://dx.doi.org/10.3390/v14102138.
White, Wendy I., Susan D. Wilson, William Bonnez, Robert C. Rose, Scott Koenig, and Joann A. Suzich. "In Vitro Infection and Type-Restricted Antibody-Mediated Neutralization of Authentic Human Papillomavirus Type 16." Journal of Virology 72, no. 2 (February 1, 1998): 959–64. http://dx.doi.org/10.1128/jvi.72.2.959-964.1998.
King, Caroline C., Denise J. Jamieson, Jeffrey Wiener, Susan Cu-Uvin, Robert S. Klein, Anne M. Rompalo, Keerti V. Shah, and Jack D. Sobel. "Bacterial Vaginosis and the Natural History of Human Papillomavirus." Infectious Diseases in Obstetrics and Gynecology 2011 (2011): 1–8. http://dx.doi.org/10.1155/2011/319460.
Sano, Takaaki. "Human Papillomavirus (HPV) Infection and Immunohistochemistry." Kitakanto Medical Journal 64, no. 4 (2014): 347–48. http://dx.doi.org/10.2974/kmj.64.347.
Prelić, Jovana, and Aleksandra Knežević. "The frequency of infection with high-risk human papilloma virus types on the cervix uteri of women of reproductive age." Medicinski podmladak 73, no. 1 (2022): 55–61. http://dx.doi.org/10.5937/mp73-33477.
NG, García. "Polymorphism of KIR Genes in Women with Human Papillomavirus Infection." Virology & Immunology Journal 7, no. 3 (July 7, 2023): 1–4. http://dx.doi.org/10.23880/vij-16000319.
Kornete, Anna, Elizabete Pumpure, Jana Zodzika, Dace Rezeberga, Liga Puksta-Gulbe, and Irina Jermakova. "Human Immunodeficiency Virus and Human Papillomavirus Co-Infection in Pregnant Woman." Acta Chirurgica Latviensis 16, no. 2 (December 1, 2016): 26–27. http://dx.doi.org/10.1515/chilat-2017-0006.
Tesfalul, Martha, Kenneth Simbiri, Chikoti M. Wheat, Didintle Motsepe, Hayley Goldbach, Kathleen Armstrong, Kathryn Hudson, Mukendi K. Kayembe, Erle Robertson, and Carrie Kovarik. "Oncogenic Viral Prevalence in Invasive Vulvar Cancer Specimens From Human Immunodeficiency Virus–Positive and -Negative Women in Botswana." International Journal of Gynecologic Cancer 24, no. 4 (May 2014): 758–65. http://dx.doi.org/10.1097/igc.0000000000000111.
Delany-Moretlwe, Sinead, A. Chikandiwa, and J. Gibbs. "Human papillomavirus infection and disease in men: Impact of HIV." Southern African Journal of HIV Medicine 14, no. 4 (November 22, 2013): 183–88. http://dx.doi.org/10.4102/sajhivmed.v14i4.55.